Kuros Biosciences Announces Three Advancements Related to its MagnetOsTM Portfolio Including…
Kuros Biosciences Announces Three Advancements Related to its MagnetOsTM Portfolio Including Impressive Fusion Data from MAXA Prospective Randomized Clinical Trial and Two 510(k) Clearances from FDANew level 1 data from the MAXA Clinical…